Portugal, April 1 -- Portugal based Otsuka Pharmaceutical Europe Ltd. has secured contract from Unidade Local De Saude De Amadora/Sintra, Epe for Acquisition Of Oral Tolvaptane (Aue 202600845) From Lab Otsuka To Ulsasi For The Year 2026. The value of the contract is worth 2430252 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....